64 related articles for article (PubMed ID: 28591597)
1. Single-Molecule Threshold of HIV Fate Decision.
Wollman R
Biophys J; 2017 Jun; 112(11):2247-2248. PubMed ID: 28591597
[TBL] [Abstract][Full Text] [Related]
2. Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch.
Aull KH; Tanner EJ; Thomson M; Weinberger LS
Biophys J; 2017 Jun; 112(11):2428-2438. PubMed ID: 28591615
[TBL] [Abstract][Full Text] [Related]
3. Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.
Razooky BS; Weinberger LS
Methods; 2011 Jan; 53(1):68-77. PubMed ID: 21167940
[TBL] [Abstract][Full Text] [Related]
4. Transient-mediated fate determination in a transcriptional circuit of HIV.
Weinberger LS; Dar RD; Simpson ML
Nat Genet; 2008 Apr; 40(4):466-70. PubMed ID: 18344999
[TBL] [Abstract][Full Text] [Related]
5. Distinct promoter activation mechanisms modulate noise-driven HIV gene expression.
Chavali AK; Wong VC; Miller-Jensen K
Sci Rep; 2015 Dec; 5():17661. PubMed ID: 26666681
[TBL] [Abstract][Full Text] [Related]
6. FoxO4 negatively controls Tat-mediated HIV-1 transcription through the post-transcriptional suppression of Tat encoding mRNA.
Oteiza A; Mechti N
J Gen Virol; 2017 Jul; 98(7):1864-1878. PubMed ID: 28699853
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
8. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator.
Kamine J; Elangovan B; Subramanian T; Coleman D; Chinnadurai G
Virology; 1996 Feb; 216(2):357-66. PubMed ID: 8607265
[TBL] [Abstract][Full Text] [Related]
9. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
10. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
Nahreini P; Mathews MB
Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945
[TBL] [Abstract][Full Text] [Related]
11. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 positive feedback and lytic fate.
Nachman I; Ramanathan S
Nat Genet; 2008 Apr; 40(4):382-3. PubMed ID: 18368125
[No Abstract] [Full Text] [Related]
13. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif.
Vacca A; Farina M; Maroder M; Alesse E; Screpanti I; Frati L; Gulino A
Biochem Biophys Res Commun; 1994 Nov; 205(1):467-74. PubMed ID: 7999066
[TBL] [Abstract][Full Text] [Related]
14. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
[TBL] [Abstract][Full Text] [Related]
15. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
Poon B; Chang MA; Chen IS
J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
[TBL] [Abstract][Full Text] [Related]
16. The HIV-1 Tat transactivator protein: a therapeutic target?
Fulcher AJ; Jans DA
IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
[TBL] [Abstract][Full Text] [Related]
17. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter.
Brès V; Kiernan RE; Linares LK; Chable-Bessia C; Plechakova O; Tréand C; Emiliani S; Peloponese JM; Jeang KT; Coux O; Scheffner M; Benkirane M
Nat Cell Biol; 2003 Aug; 5(8):754-61. PubMed ID: 12883554
[TBL] [Abstract][Full Text] [Related]
18. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
Mousseau G; Valente ST
Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
Rittner K; Churcher MJ; Gait MJ; Karn J
J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB.
Veschambre P; Roisin A; Jalinot P
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2235-45. PubMed ID: 9292011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
